Viktor Kožich1, Tamás Ditrói2, Jitka Sokolová1, Michaela Křížková1, Jakub Krijt1, Pavel Ješina1, Peter Nagy2. 1. Department of Paediatrics and Adolescent Medicine, Charles University - First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic. 2. Department of Molecular Immunology and Toxicology, National Institute of Oncology, Budapest, Hungary.
Abstract
BACKGROUND AND PURPOSE: Homocystinurias are rare genetic defects characterized by altered fluxes of sulfur compounds including homocysteine and cysteine. We explored whether the severely perturbed sulfur amino acid metabolism in patients with homocystinurias affects the metabolism of hydrogen sulfide. EXPERIMENTAL APPROACH: We studied 10 treated patients with a block in the conversion of homocysteine to cysteine due to cystathionine β-synthase deficiency (CBSD) and six treated patients with remethylation defects (RMD) and an enhanced flux of sulfur metabolites via transsulfuration. Control groups for CBSD and RMD patients consisted of 22 patients with phenylketonuria on a low-protein diet and of 12 healthy controls respectively. Plasma and urine concentrations of selected sulfur compounds were analysed by HPLC and LC-MS/MS. KEY RESULTS: Patients with CBSD exhibited plasma concentrations of monobromobimane-detected sulfide similar to appropriate controls. Urinary homolanthionine and thiosulfate in CBSD were increased significantly 1.9 and 3 times suggesting higher hydrogen sulfide synthesis by γ-cystathionase and detoxification respectively. Surprisingly, patients with RMD had significantly lower plasma sulfide levels (53 and 64% of controls) with lower sulfite concentrations, and higher taurine and thiosulfate levels suggesting enhanced cysteine oxidation and hydrogen sulfide catabolism respectively. CONCLUSION AND IMPLICATIONS: The results from this study suggest that severe inherited defects in sulfur amino acid metabolism may be accompanied by only moderately perturbed hydrogen sulfide metabolism and lends support to the hypothesis that enzymes in the transsulfuration pathway may not be the major contributors to the endogenous hydrogen sulfide pool. LINKED ARTICLES: This article is part of a themed section on Chemical Biology of Reactive Sulfur Species. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.4/issuetoc.
BACKGROUND AND PURPOSE:Homocystinurias are rare genetic defects characterized by altered fluxes of sulfur compounds including homocysteine and cysteine. We explored whether the severely perturbed sulfur amino acid metabolism in patients with homocystinurias affects the metabolism of hydrogen sulfide. EXPERIMENTAL APPROACH: We studied 10 treated patients with a block in the conversion of homocysteine to cysteine due to cystathionine β-synthase deficiency (CBSD) and six treated patients with remethylation defects (RMD) and an enhanced flux of sulfur metabolites via transsulfuration. Control groups for CBSD and RMDpatients consisted of 22 patients with phenylketonuria on a low-protein diet and of 12 healthy controls respectively. Plasma and urine concentrations of selected sulfur compounds were analysed by HPLC and LC-MS/MS. KEY RESULTS:Patients with CBSD exhibited plasma concentrations of monobromobimane-detected sulfide similar to appropriate controls. Urinary homolanthionine and thiosulfate in CBSD were increased significantly 1.9 and 3 times suggesting higher hydrogen sulfide synthesis by γ-cystathionase and detoxification respectively. Surprisingly, patients with RMD had significantly lower plasma sulfide levels (53 and 64% of controls) with lower sulfite concentrations, and higher taurine and thiosulfate levels suggesting enhanced cysteine oxidation and hydrogen sulfide catabolism respectively. CONCLUSION AND IMPLICATIONS: The results from this study suggest that severe inherited defects in sulfur amino acid metabolism may be accompanied by only moderately perturbed hydrogen sulfide metabolism and lends support to the hypothesis that enzymes in the transsulfuration pathway may not be the major contributors to the endogenous hydrogen sulfide pool. LINKED ARTICLES: This article is part of a themed section on Chemical Biology of Reactive Sulfur Species. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.4/issuetoc.
Authors: Edward A Wintner; Thomas L Deckwerth; William Langston; Asa Bengtsson; Dina Leviten; Paul Hill; Michael A Insko; Ronald Dumpit; Emily VandenEkart; Christopher F Toombs; Csaba Szabo Journal: Br J Pharmacol Date: 2010-06 Impact factor: 8.739
Authors: Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2017-12 Impact factor: 8.739
Authors: Virág Bogdándi; Tomoaki Ida; Thomas R Sutton; Christopher Bianco; Tamás Ditrói; Grielof Koster; Hillary A Henthorn; Magda Minnion; John P Toscano; Albert van der Vliet; Michael D Pluth; Martin Feelisch; Jon M Fukuto; Takaaki Akaike; Péter Nagy Journal: Br J Pharmacol Date: 2018-08-23 Impact factor: 8.739
Authors: Viktor Kožich; Jakub Krijt; Jitka Sokolová; Petra Melenovská; Pavel Ješina; Roman Vozdek; Tomáš Majtán; Jan P Kraus Journal: Biochimie Date: 2016-01-11 Impact factor: 4.079
Authors: Martina Huemer; Daria Diodato; Bernd Schwahn; Manuel Schiff; Anabela Bandeira; Jean-Francois Benoist; Alberto Burlina; Roberto Cerone; Maria L Couce; Angeles Garcia-Cazorla; Giancarlo la Marca; Elisabetta Pasquini; Laura Vilarinho; James D Weisfeld-Adams; Viktor Kožich; Henk Blom; Matthias R Baumgartner; Carlo Dionisi-Vici Journal: J Inherit Metab Dis Date: 2016-11-30 Impact factor: 4.982
Authors: Arjan Pol; G Herma Renkema; Albert Tangerman; Edwin G Winkel; Udo F Engelke; Arjan P M de Brouwer; Kent C Lloyd; Renee S Araiza; Lambert van den Heuvel; Heymut Omran; Heike Olbrich; Marijn Oude Elberink; Christian Gilissen; Richard J Rodenburg; Jörn Oliver Sass; K Otfried Schwab; Hendrik Schäfer; Hanka Venselaar; J Silvia Sequeira; Huub J M Op den Camp; Ron A Wevers Journal: Nat Genet Date: 2017-12-18 Impact factor: 38.330
Authors: Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies Journal: Nucleic Acids Res Date: 2018-01-04 Impact factor: 16.971
Authors: J Krijt; J Sokolová; J Šilhavý; P Mlejnek; J Kubovčiak; F Liška; H Malínská; M Hüttl; I Marková; M Křížková; M H Stipanuk; T Křížek; T Ditroi; P Nagy; V Kožich; M Pravenec Journal: Physiol Res Date: 2021-09-10 Impact factor: 1.881
Authors: Katalin Erdélyi; Tamás Ditrói; Henrik J Johansson; Ágnes Czikora; Noémi Balog; Laxmi Silwal-Pandit; Tomoaki Ida; Judit Olasz; Dorottya Hajdú; Zoltán Mátrai; Orsolya Csuka; Koji Uchida; József Tóvári; Olav Engebraten; Takaaki Akaike; Anne-Lise Børresen Dale; Miklós Kásler; Janne Lehtiö; Péter Nagy Journal: Proc Natl Acad Sci U S A Date: 2021-11-09 Impact factor: 11.205